MARKETSNatco Pharma Shares Rise on Rs 2,500 Crore Expansion StrategyAli WaghbakriwalaJuly 9, 2026July 9, 2026 July 9, 2026July 9, 2026 Shares of Natco Pharma Ltd climbed nearly 2% on 9 July after the company announced a major investment plan worth around Rs 2,500 crore to...
BUSINESSNatco Pharma Launched a Generic Version of Celgene’s Pomalyst in US Ali WaghbakriwalaMarch 3, 2026March 3, 2026 March 3, 2026March 3, 2026 Natco Pharma Ltd said on Tuesday, 3 March, that it and its partner Breckenridge Pharmaceutical have introduced Pomalidomide capsules, a generic version of Celgene’s Pomalyst,...
MARKETSNatco Pharma Gets CDSCO Nod; Shares Rally 12.5%Dhruva KulkarniFebruary 16, 2026February 16, 2026 February 16, 2026February 16, 2026 Shares of Natco Pharma Ltd rallied 12.5% to touch a day’s high of Rs 932 on 16th February. This happened after the company said it...